logo

For the Inventor, By the Inventor

Foster City, CA, United States of America

Gilead Sciences, Inc.


USPTO Granted Patents = 928



Trademarks = 145

Forward Citations = 19,872

Loading Chart...
Loading Chart...

986 inventors (with patents filed for the assignee):

goldMedal Richard L Mackman (91 out of 95 patents)

silverMedal William John Watkins (84 out of 92 patents)

bronzeMedal Jeff A Zablocki (75 out of 158 patents)

4.  Choung U Kim (67 out of 87 patents)

5.  John O Link (60 out of 99 patents)

6.  Hyung-Jung Pyun (59 out of 67 patents)

7.  Michael Graupe (55 out of 75 patents)

8.  Dustin S Siegel (55 out of 57 patents)

9.  James G Taylor (53 out of 95 patents)

10.  Scott E Lazerwith (50 out of 55 patents)

11.  Aesop Cho (48 out of 56 patents)

12.  Larry M Gold (48 out of 191 patents)

13.  Chandrasekar Venkataramani (47 out of 60 patents)

14.  Jennifer R Zhang (46 out of 48 patents)

15.  Jeromy J Cottell (43 out of 60 patents)


Core Competencies:
Toll-Like Receptor Modulators
HIV Inhibitor Compounds
Phospholipid Compounds
PARP7 Inhibitors
KRAS G12D Modulating Compounds
SARS-CoV2 Main Protease Inhibitors
MCL1 Inhibitors
PD-1/PD-L1 Inhibitors
HBV Vaccines
Antiviral Compounds
GLP-1R Modulating Compounds
Multi-Specific Antigen Binding Molecules

928 patents:

1. 12528814 - Bifunctional degraders of interleukin-1 receptor-associated kinases and therapeutic use thereof (2026-01-20),
2. 12522582 - ANTIVIRAL INDOLINYL COMPOUNDS AND USES THEREOF (2026-01-13),
3. 12522570 - Toll like receptor modulator compounds (2026-01-13),
4. 12521388 - Substituted dipyrido[1,2-a:1',2′-d]pyrazines for treating viral infections (2026-01-13),
5. 12509466 - Methods and compounds for treating paramyxoviridae virus infections (2025-12-30),
6. 12503454 - LPA receptor antagonists and uses thereof (2025-12-23),
7. 12497408 - Tetracyclic compounds and methods for the treatment of Zika virus infection (2025-12-16),
8. 12497382 - GLP-1R modulating compounds (2025-12-16),
9. 12492189 - Solid forms of an HIV capsid inhibitor (2025-12-09),
10. 12486271 - Solid forms of a toll-like receptor modulator (2025-12-02),
11. 12486252 - Solid forms of a Cot inhibitor compound (2025-12-02),
12. 12479853 - HIV inhibitor compounds (2025-11-25),
13. 12473314 - Phospholipid compounds and uses thereof (2025-11-18),
14. 12473271 - GLP-1R modulating compounds (2025-11-18),
15. 12459922 - PARP7 inhibitors (2025-11-04),
Gilead Sciences, Inc. is a biopharmaceutical company focusing on the research, development, and production of innovative medicines and therapeutics. Gilead aims to provide solutions for some of the world's most challenging diseases, including HIV/AIDS, viral hepatitis, cancer, and respiratory conditions. With a commitment to advancing patient care and improving global health, Gilead continually invests in cutting-edge scientific research and collaborations to drive medical advancements.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 20 2026

...
928 Patents

#2 in Foster City, CA

#134 in California

#537 in US

#1,068 in the World

...
Foster City, CA, United States of America

Gilead Sciences, Inc.

Forward Citations = 19,872

986 inventors:

goldMedal Richard L Mackman (91 out of 95 patents)

silverMedal William John Watkins (84 out of 92 patents)

bronzeMedal Jeff A Zablocki (75 out of 158 patents)

4.  Choung U Kim (67 out of 87 patents)

5.  John O Link (60 out of 99 patents)

Please report any incorrect information to support@idiyas.com
Loading…